Omnicell Inc (OMCL) Faces Fiscal Challenges Despite Strong Innovation Pipeline [Yahoo! Finance]
Omnicell, Inc. (OMCL)
Last omnicell, inc. earnings: 2/6 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.omnicell.com
Company Research
Source: Yahoo! Finance
Net Loss : GAAP net loss for the full year 2023 was $20 million, a decline from a net income of $6 million in 2022. Earnings Per Share : GAAP net loss per diluted share was $0.45 for 2023, compared to net income per diluted share of $0.12 in 2022. Non-GAAP EBITDA : Full year 2023 Non-GAAP EBITDA decreased to $138 million from $193 million in the previous year. Free Cash Flow : Non-GAAP Free Cash Flow for 2023 was $126 million. Bookings and Backlog : Total bookings for 2023 were $854 million, a 19% decrease year-over-year, with a total backlog of $1.142 billion. Warning! GuruFocus has detected 3 Warning Sign with OMCL. On February 8, 2024, Omnicell Inc ( NASDAQ:OMCL ) released its 8-K filing , detailing its fiscal year and fourth quarter results for the period ended December 31, 2023. Omnicell, a leader in pharmacy automation and business analytics for healthcare providers, reported a decrease in total GAAP revenues for the year, reflecting ongoing challenges in the health
Show less
Read more
Impact Snapshot
Event Time:
OMCL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OMCL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OMCL alerts
High impacting Omnicell, Inc. news events
Weekly update
A roundup of the hottest topics
OMCL
News
- Clover Health Appoints Healthcare Technology Veteran Peter Kuipers as Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- Omnicell Announces XT Amplify [Yahoo! Finance]Yahoo! Finance
- Omnicell Announces XT AmplifyBusiness Wire
- Investors in Omnicell (NASDAQ:OMCL) have unfortunately lost 80% over the last three years [Yahoo! Finance]Yahoo! Finance
- Pharmacy Automation Devices Market Size is expected to reach USD 12.21 billion by 2031, growing at a CAGR of 8.9%: Straits Research [Yahoo! Finance]Yahoo! Finance
OMCL
Earnings
- 2/8/24 - Beat
OMCL
Sec Filings
- 4/11/24 - Form ARS
- 4/4/24 - Form DEF
- 3/19/24 - Form 4
- OMCL's page on the SEC website